Gratifying cosmetic and functional results could be achieved in all 26 patients who underwent surgery.

We wish to highlight the diversity of presentations in orbital carcinoid. One patient presented with headache, while the other presented with recurrent transient ptosis. To the best of our knowledge, there have been no previous reports of OCM presenting as transient ptosis. The value of Indium-Octreotide scan in detecting the true extent of systemic disease and reducing the need for biopsy in carcinoid tumour is discussed.

Migration of dermal filler is a rare complication in the periocular area. We describe a case that highlights the diagnostic and therapeutic dilemmas posed. A patient presented with a bluish swelling involving the left brow, temple, and glabella. It was ill-defined, mobile, and nontender. An MRI suggested a vascular malformation, while an ultrasound suggested a dermoid. On further questioning, the patient revealed having a permanent polyalkylimide filler injected to the glabella 10 years ago. This raised the possibility of delayed migration. The eyebrow, temple, and glabella were explored through a skin-crease incision. Transparent gel was expressed and cicatrized granulomas were excised. The patient made an excellent recovery through an inconspicuous incision. This case emphasizes the importance of taking a detailed history and revisiting the diagnosis, if necessary. We describe a relatively scar-free approach to remove widely distributed migrated fillers. Clinical and radiologic features of migrated filler can mimic tumor.

Aim Obesity is associated with adverse outcomes in end-stage renal disease (ESRD) and kidney transplant (KT) recipients. Bariatric surgery (BS) is an effective solution to obesity. The authors aim to summarise the evidence for the efficacy and safety of BS in ESRD or KT. Method A literature search was conducted using MEDLINE, EMBASE and Web of Science from inception to date (April 2021). Articles were categorised into patients awaiting waiting list acceptance, awaiting transplantation, undergoing simultaneous BS and kidney transplantation, and undergoing BS following transplantation in the past. Primary outcome was change in BMI with secondary outcomes as adverse events, graft outcomes and KT. Results Twenty-eight articles were selected: fourteen on patients awaiting listing (n = 1984), nine on patients listed for KT (n = 196), one on simultaneous BS and KT and ten on patients undergoing BS following KT (n = 198). Mean change in BMI for patients awaiting listing was -10.5 (-4.1 to -17.0, p = 0.001), change in BMI for patients listed for KT was -11.2 (-9.5 to -12.9, p<0.001) and change for patients with prior KT was -11.0 (-7.09 to -14.9, p<0.001). 60.4% of patients undergoing BS were successfully listed for KT. 74.1% of patients listed for KT undergoing BS underwent KT within 17 months (SD = 78.5). Time from KT to BS was 59.2 months (SD = 43.0). Conclusion BS is both safe and efficacious on patients with ESRD, those awaiting KT, and those with prior KT and should be considered when obesity is a hurdle to favourable outcomes.